United Therapeutics (UTHR) Insider Trading & Ownership $386.27 -14.18 (-3.54%) (As of 11/14/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends United Therapeutics (NASDAQ:UTHR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.90%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$126.94 M Get UTHR Insider Trade Alerts Want to know when executives and insiders are buying or selling United Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address UTHR Insider Buying and Selling by Quarter Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here United Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/11/2024Judy D OlianDirectorSell1,750$412.48$721,840.00 11/11/2024Michael BenkowitzCOOSell15,000$407.32$6,109,800.00 11/8/2024Nilda MesaDirectorSell224$412.28$92,350.72 11/7/2024Michael BenkowitzCOOSell15,000$401.44$6,021,600.00 11/1/2024Christopher CauseyDirectorSell510$376.63$192,081.30 11/1/2024Michael BenkowitzCOOSell14,700$374.46$5,504,562.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/28/2024James EdgemondCFOSell7,800$350.00$2,730,000.00 10/21/2024James EdgemondCFOSell7,782$366.99$2,855,916.18 10/14/2024James EdgemondCFOSell7,792$355.88$2,773,016.96 10/7/2024James EdgemondCFOSell7,794$355.54$2,771,078.76 9/30/2024James EdgemondCFOSell7,792$358.62$2,794,367.04 9/23/2024James EdgemondCFOSell7,796$354.04$2,760,095.84 9/9/2024James EdgemondCFOSell7,802$345.41$2,694,888.82 9/3/2024James EdgemondCFOSell7,785$362.37$2,821,050.45 8/26/2024Martine A RothblattCEOSell269$348.41$93,722.29 8/19/2024Martine A RothblattCEOSell3,600$344.18$1,239,048.00 8/8/2024Martine A RothblattCEOSell3,600$328.39$1,182,204.00 8/7/2024Michael BenkowitzCOOSell25,000$323.38$8,084,500.00 8/6/2024Martine A RothblattCEOSell3,600$325.45$1,171,620.00 8/2/2024Martine A RothblattCEOSell3,600$324.73$1,169,028.00 8/2/2024Raymond DwekDirectorSell5,000$325.35$1,626,750.00 7/30/2024Martine A RothblattCEOSell3,600$337.40$1,214,640.00 7/26/2024Martine A RothblattCEOSell3,600$338.61$1,218,996.00 7/24/2024Martine A RothblattCEOSell3,600$334.00$1,202,400.00 7/22/2024Martine A RothblattCEOSell3,600$331.32$1,192,752.00 7/18/2024Martine A RothblattCEOSell3,600$331.79$1,194,444.00 7/16/2024Martine A RothblattCEOSell3,600$328.03$1,180,908.00 7/12/2024Martine A RothblattCEOSell3,600$324.97$1,169,892.00 7/10/2024Martine A RothblattCEOSell3,600$326.35$1,174,860.00 7/8/2024Martine A RothblattCEOSell3,600$317.05$1,141,380.00 7/5/2024Martine A RothblattCEOSell3,600$313.25$1,127,700.00 7/3/2024Martine A RothblattCEOSell3,600$312.48$1,124,928.00 7/1/2024Martine A RothblattCEOSell3,600$320.45$1,153,620.00 6/27/2024Martine A RothblattCEOSell3,600$316.62$1,139,832.00 6/25/2024Nilda MesaDirectorSell266$318.58$84,742.28 6/24/2024Martine A RothblattCEOSell3,600$315.97$1,137,492.00 6/21/2024Martine A RothblattCEOSell3,600$313.91$1,130,076.00 6/14/2024Martine A RothblattCEOSell3,600$287.22$1,033,992.00 6/13/2024Christopher CauseyDirectorSell2,000$281.53$563,060.00 6/12/2024Martine A RothblattCEOSell3,600$281.19$1,012,284.00 [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin6/10/2024Martine A RothblattCEOSell3,600$273.95$986,220.00 6/7/2024Martine A RothblattCEOSell3,600$277.13$997,668.00 5/31/2024Martine A RothblattCEOSell3,600$272.48$980,928.00 5/28/2024Martine A RothblattDirectorSell3,600$269.06$968,616.00 5/23/2024Martine A RothblattDirectorSell3,600$275.78$992,808.00 5/21/2024Martine A RothblattDirectorSell1,468$275.85$404,947.80 5/16/2024Martine A RothblattDirectorSell3,600$272.37$980,532.00 5/14/2024Christopher PatuskyDirectorSell1,310$264.35$346,298.50 5/13/2024Martine A RothblattCEOSell3,600$265.48$955,728.00 5/9/2024Martine A RothblattCEOSell3,600$264.22$951,192.00 5/6/2024Martine A RothblattCEOSell3,600$259.70$934,920.00 5/3/2024Christopher CauseyDirectorSell2,240$259.91$582,198.40 5/2/2024Martine A RothblattCEOSell3,600$258.09$929,124.00 4/30/2024Martine A RothblattCEOSell3,600$235.35$847,260.00 4/26/2024Martine A RothblattCEOSell3,600$235.20$846,720.00 4/24/2024Martine A RothblattCEOSell3,600$238.81$859,716.00 4/22/2024Martine A RothblattCEOSell3,600$236.47$851,292.00 4/18/2024Martine A RothblattCEOSell3,600$237.91$856,476.00 4/16/2024Martine A RothblattCEOSell3,600$232.05$835,380.00 4/12/2024Martine A RothblattCEOSell3,600$235.42$847,512.00 4/10/2024Martine A RothblattCEOSell13,800$237.27$3,274,326.00 4/8/2024Martine A RothblattCEOSell5,060$237.52$1,201,851.20 4/4/2024Martine A RothblattCEOSell15,000$233.27$3,499,050.00 4/4/2024Paul A MahonEVPSell6,000$232.37$1,394,220.00 3/28/2024Martine A RothblattCEOSell14,125$236.18$3,336,042.50 3/27/2024Nilda MesaDirectorSell325$237.80$77,285.00 3/26/2024Martine A RothblattCEOSell15,000$248.33$3,724,950.00 3/22/2024Martine A RothblattCEOSell15,000$237.05$3,555,750.00 3/21/2024Paul A MahonEVPSell6,000$236.45$1,418,700.00 3/19/2024Martine A RothblattCEOSell15,000$236.59$3,548,850.00 2/23/2024Christopher PatuskyDirectorSell1,680$224.00$376,320.00 2/15/2024Paul A MahonEVPSell6,000$215.31$1,291,860.00 2/1/2024Paul A MahonEVPSell6,000$215.01$1,290,060.00 1/18/2024Paul A MahonEVPSell6,000$218.72$1,312,320.00 1/4/2024Paul A MahonEVPSell6,000$227.97$1,367,820.00 12/21/2023Paul A MahonEVPSell6,000$229.27$1,375,620.00 12/19/2023Nilda MesaDirectorSell605$244.90$148,164.50 12/12/2023Christopher CauseyDirectorSell3,000$249.68$749,040.00 12/7/2023Paul A MahonEVPSell6,000$238.89$1,433,340.00 (Data available from 1/1/2013 forward) UTHR Insider Trading Activity - Frequently Asked Questions Who is on United Therapeutics's Insider Roster? The list of insiders at United Therapeutics includes Christopher Causey, Christopher Patusky, James Edgemond, Judy D Olian, Louis W Sullivan, Martine A Rothblatt, Michael Benkowitz, Nilda Mesa, Paul A Mahon, and Raymond Dwek. Learn more on insiders at UTHR. What percentage of United Therapeutics stock is owned by insiders? 11.90% of United Therapeutics stock is owned by insiders. Learn more on UTHR's insider holdings. Which United Therapeutics insiders have been buying company stock? The following insider purchased UTHR shares in the last 24 months: Christopher Patusky ($684.36). How much insider buying is happening at United Therapeutics? Insiders have purchased a total of 6 UTHR shares in the last 24 months for a total of $684.36 bought. Which United Therapeutics insiders have been selling company stock? The following insiders have sold UTHR shares in the last 24 months: Christopher Causey ($2,086,379.70), Christopher Patusky ($723,157.05), James Edgemond ($22,200,414.05), Judy D Olian ($1,006,660.00), Louis W Sullivan ($572,236.00), Martine A Rothblatt ($157,796,530.29), Michael Benkowitz ($25,720,462.00), Nilda Mesa ($568,045.32), Paul A Mahon ($37,256,955.00), and Raymond Dwek ($1,626,750.00). How much insider selling is happening at United Therapeutics? Insiders have sold a total of 933,157 United Therapeutics shares in the last 24 months for a total of $249,557,589.41 sold. United Therapeutics Key ExecutivesDr. Martine A. Rothblatt J.D. (Age 69)M.B.A., Ph.D., Founder, Chairman & CEO Compensation: $5.66M29 recent tradesMr. Michael I. Benkowitz (Age 52)President & COO Compensation: $3.26M4 recent tradesMr. James C. Edgemond (Age 56)CFO & Treasurer Compensation: $2.15M8 recent tradesMr. Paul A. Mahon J.D. (Age 60)Executive VP, General Counsel & Corporate Secretary Compensation: $2.44MMr. Dewey Steadman C.F.A.Head of Investor RelationsMs. Holly HobsonAssociate Vice President of Human ResourcesKevin T. GraySenior Vice President of Strategic Operations & LogisticsMr. Patrick Poisson (Age 56)Executive VP of Technical Operations Dr. Leigh PetersonExecutive Vice President of Product Development & XenotransplantationMr. Gil GoldenSenior VP & Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies TEVA Insider Selling BPMC Insider Selling BBIO Insider Selling BHVN Insider Selling PRGO Insider Selling BHC Insider Selling ARWR Insider Selling ALNY Insider Selling BIIB Insider Selling INCY Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NASDAQ:UTHR) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
